Lyfebulb and the Parkinson School seek a wide range of solutions that will improve population and public health, health care delivery, and/or health equity in response to emerging infectious diseases such as COVID-19. Applying organizations must be registered in the United States.
ABOUT THE VIRTUAL SUMMIT AND $75,000 PRIZE MONEY
The 2021 Lyfebulb and Loyola University Chicago Innovation Challenge: Meeting Our Moment – Reimagining Innovation, Improving Health Equity, and Building Resiliency will source innovative solutions, technologies, methodologies, and services that address the effects of emerging infectious diseases (such as the COVID-19 pandemic) by improving population and public health, health care delivery, and/or health equity.
The Innovation Challenge is open to applicants from different industries and disciplines. Innovators from underserved communities are encouraged to apply. Solutions may include, but are not limited to, digital technologies, devices, consumer products and solutions, and community programs and services.
The Innovation Challenge will be held during a virtual summit on November 16-17, 2021. Applications are open; the deadline to submit entries is September 17, 2021. Selected finalists will receive an invitation to pitch their innovations to an expert panel of judges consisting of public health experts, community advocates, and healthcare industry leaders. A total of $75,000 will be distributed among no more than three finalists to advance the development of their innovation. The 2021 Innovation Challenge is funded by the generous endowment from Bob and Betty Parkinson, which created Loyola University Chicago’s Parkinson School of Health Sciences and Public Health.
In addition to presenting their social ventures and innovative concepts, finalists will have the opportunity to exchange ideas on how to advance innovation in the areas of population and public health, health care delivery, and health equity, and to engage with Lyfebulb founders, Parkinson School leadership, key opinion leaders, and potential partners and investors.
THE 2021 INNOVATION CHALLENGE
Through a call-to-action and an invitation to “meet our moment,” the 2021 Innovation Challenge seeks innovative ideas and solutions to address the effects of emerging infectious diseases through advancements in the areas of population and public health, health care delivery, and health equity.
The problem: Over the past several decades, emerging infectious diseases have increased in frequency annually both in the United States and globally. The COVID-19 pandemic is just one example of their devastating impacts on already overburdened health care systems and on the health and well-being of communities across the country and around the world.
The opportunity: COVID-19 and the shortcomings of the U.S. response highlighted the need for more forward-thinking, interdisciplinary, and creative strategies that build resiliency and improve preparedness to better manage pandemics and public health threats. In particular, the pandemic magnified existing social, economic, and racial inequalities and exposed the profound inequities at all levels of the U.S. health system. This Innovation Challenge will help identify barriers to care access, work to understand the underlying causes of health disparities, and advance health equity for all.
We’re reimagining innovation: In response to these challenges and with our vision that multi-sectoral and interdisciplinary cooperation is essential to address them, the Parkinson School, in partnership with Lyfebulb, seeks to reimagine innovation in the population and public health, health care delivery, and health equity space.
CEO at Yumlish
CEO at One Stop Wellness
Founder and CEO at Lief Therapeutics
Founder and CEO at Aidar Health
Co-Founder and CEO at IKONA Health
Kimberly Gandy, MD, PhD
Founder and CEO at Play-it Health
Katherine Grill, PhD
Co-founder and CEO at Neolth
Yair Saperstein, MD
Co-founder and CEO at avoMD
Founder and President at UE LifeSciences
CEO at LyfLynks
Jerry Wilmink, PhD
Chief Business Development Officer at CarePredict
Lisa Hehenberger, PhD
Associate Professor, Department of Strategy and General Management at ESADE Business School and Director at ESADE Entrepreneurship Institute & Center for Social Impact
Managing Director at Symbiotix at Havas Health & You
Ramanathan Raju, MD, MBA, FRCS, FACS, FACHE
Former Senior Vice President and Chief Community Health Investment Officer at Northwell Health New York, Former President and CEO at NYC Health and Hospitals, and Former CEO at Cook County Health System Chicago
Abigail Silva, PhD, MPH
Assistant Professor at the Parkinson School of Health Sciences and Public Health and Director at the Institute of Public Health at Loyola University Chicago
Chief Technology Officer at Lyfebulb, IT/Digital Product Advisor, and Managing Partner at Yang Consulting
Join the 2021 Innovation Challenge
- Address both the immediate and long-term effects of emerging infectious diseases such as COVID-19 by improving population health, public health, health care delivery, and/or health equity
- Digital technologies, devices, consumer products and solutions, and community programs and services; technology and systems solutions addressing health care delivery are encouraged to apply
- Communities, particularly underserved populations
- Health care delivery systems and providers
- U.S. entities
- For-profit companies (e.g., C Corp, LLC, etc.)
- 501(c)(3) non-profit organizations
- Individuals with registered organizations
Submissions will be evaluated by a panel of subject matter experts selected by Lyfebulb and the Parkinson School.
The judging panel will assess the following:
- What is the strategic basis for the identified problem/gap or public health challenge (e.g., research conducted)?
- How is the public health challenge or effect of emerging infectious disease(s) specifically addressed?
- Does the innovation have the potential to improve population or public health outcomes, health care delivery, and/or health equity?
- What level of impact will the innovation make?
- What metrics will the organization use to measure and demonstrate this impact?
FEASIBILITY & SUSTAINABILITY
- How is the innovation unique to the market or public health landscape?
- What is the feasibility of development and implementation into the marketplace or healthcare ecosystem (e.g., funding, regulations, testing requirements, etc.)?
THE CHALLENGE IN NUMBERS
Applications open on Monday, August 2, 2021
Applications close on Friday, September 17, 2021, at 11:59 PM EDT
The virtual 2021 Innovation Challenge will take place November 16-17, 2021
A total of $75,000 will be distributed among no more than three finalists